Dishman Carbogen Amcis Ltd
NSE:DCAL

Watchlist Manager
Dishman Carbogen Amcis Ltd Logo
Dishman Carbogen Amcis Ltd
NSE:DCAL
Watchlist
Price: 228.44 INR 4.54% Market Closed
Market Cap: 35.8B INR
Have any thoughts about
Dishman Carbogen Amcis Ltd?
Write Note

Dishman Carbogen Amcis Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Dishman Carbogen Amcis Ltd
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Dishman Carbogen Amcis Ltd
NSE:DCAL
Cost of Revenue
-â‚ą5B
CAGR 3-Years
-4%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Divi's Laboratories Ltd
NSE:DIVISLAB
Cost of Revenue
-â‚ą32.9B
CAGR 3-Years
-12%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
Suven Life Sciences Ltd
NSE:SUVEN
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Syngene International Ltd
NSE:SYNGENE
Cost of Revenue
-â‚ą9.1B
CAGR 3-Years
-11%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
Tarsons Products Ltd
NSE:TARSONS
Cost of Revenue
-â‚ą822.1m
CAGR 3-Years
1%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
Innova Captab Ltd
NSE:INNOVACAP
Cost of Revenue
-â‚ą7.6B
CAGR 3-Years
-33%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Dishman Carbogen Amcis Ltd
Glance View

Market Cap
35.8B INR
Industry
Life Sciences Tools & Services

Dishman Carbogen Amcis Ltd. is a manufacturing company, which engages in the provision of outsourcing services for the pharmaceutical industry. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2017-09-21. The firm's segments include CRAMS and Vitamin - D, Bulk Drugs, Quats, Specialty Chemicals and traded goods. The firm assists pharma companies through various stages of drug development from process research and development to late-stage clinical and commercial manufacturing facilities, along with the supply of active pharmaceutical ingredients (APIs) and intermediates. The firm has manufacturing and research facilities in India, Switzerland, France, Netherlands, United Kingdom and China. The firm's subsidiaries include CARBOGEN AMCIS (Shanghai) Co. Ltd, Dishman Infrastructure Ltd., Dishman Carbogen Amcis (Singapore) Pte. Ltd., CARBOGEN AMCIS Holding AG and Dishman Biotech Ltd.

DCAL Intrinsic Value
232.67 INR
Undervaluation 2%
Intrinsic Value
Price

See Also

What is Dishman Carbogen Amcis Ltd's Cost of Revenue?
Cost of Revenue
-5B INR

Based on the financial report for Jun 30, 2024, Dishman Carbogen Amcis Ltd's Cost of Revenue amounts to -5B INR.

What is Dishman Carbogen Amcis Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-3%

Over the last year, the Cost of Revenue growth was 14%. The average annual Cost of Revenue growth rates for Dishman Carbogen Amcis Ltd have been -4% over the past three years , -3% over the past five years .

Back to Top